Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KRROKorro Bio, Inc.FY2025 · Dec |
|---|---|
| Revenue | $6.39M |
| Revenue, yoy | +181.5% |
| Net income | $117.26M |
| Net income, yoy | −40.3% |
| Net margin | -1,834.5% |
| Free cash flow | $79.08M |
| FCF margin | -1,237.2% |
| EPS, diluted | $12.48 |
Add another company.